Doximity, Inc.
DOCS
$51.28
-$1.93-3.63%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 550.17M | 516.85M | 493.63M | 475.42M | 468.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 550.17M | 516.85M | 493.63M | 475.42M | 468.33M |
| Cost of Revenue | 53.97M | 51.98M | 51.07M | 50.67M | 51.78M |
| Gross Profit | 496.19M | 464.87M | 442.56M | 424.75M | 416.55M |
| SG&A Expenses | 183.84M | 176.00M | 170.87M | 170.01M | 169.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 326.20M | 313.89M | 304.56M | 302.66M | 304.36M |
| Operating Income | 223.97M | 202.96M | 189.07M | 172.77M | 163.98M |
| Income Before Tax | 253.13M | 226.33M | 203.85M | 185.20M | 173.97M |
| Income Tax Expenses | 51.79M | 52.22M | 43.30M | 37.62M | 36.33M |
| Earnings from Continuing Operations | 201.35 | 174.11 | 160.55 | 147.58 | 137.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 201.35M | 174.11M | 160.55M | 147.58M | 137.63M |
| EBIT | 223.97M | 202.96M | 189.07M | 172.77M | 163.98M |
| EBITDA | 228.85M | 207.89M | 194.19M | 178.03M | 169.90M |
| EPS Basic | 1.08 | 0.93 | 0.86 | 0.78 | 0.72 |
| Normalized Basic EPS | 0.86 | 0.77 | 0.71 | 0.64 | 0.60 |
| EPS Diluted | 1.00 | 0.87 | 0.80 | 0.72 | 0.67 |
| Normalized Diluted EPS | 0.80 | 0.72 | 0.66 | 0.59 | 0.55 |
| Average Basic Shares Outstanding | 745.78M | 744.93M | 751.79M | 760.70M | 767.77M |
| Average Diluted Shares Outstanding | 802.97M | 801.20M | 809.81M | 822.94M | 834.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |